INTRODUCTION
============

Relapsing polychondritis (RP) is an uncommon disorder of unknown etiology that is characterized by recurrent and progressive inflammation of cartilaginous structures. A minority of patients with RP develop central nervous system (CNS) manifestations,^[@ref1])^ and limbic encephalitis has also been reported.^[@ref1]-[@ref5])^ Glucocorticoid has been used as the first-line therapeutic agent,^[@ref1]-[@ref22])^ but a standardized second-line therapeutic protocol for RP with CNS manifestations has not been established. The effects of anti- tumor necrosis factor (TNF) -α agents have been reported recently.^[@ref5],[@ref9])^ We report a patient with limbic encephalitis associated with RP who was refractory to initial high-dose glucocorticoid therapy, but subsequently responded to infliximab and discontinued therapy without recurrence. We also reviewed cases of RP with CNS manifestations using PubMed with regard to clinical manifestations and treatment.

CASE PRESENTATION
=================

A 58-year-old Japanese male architect was brought to our institution by his wife, presenting with amnesia, disorientation, emotional liability and urinary incontinence. One year prior to admission, he had bilateral ear pain with swelling and erythema which improved without any treatment over a 4-week period. Nine months prior to admission, he experienced iritis and scleritis in addition to recurrent pain in bilateral auricles. Subsequent biopsy of the left auricle revealed infiltration of inflammatory cells in the perichondrium ([Fig. 1](#fig1){ref-type="fig"}). Diagnosis of RP was made based on McAdam's criteria, modified by Damiani and Levine.^[@ref23],[@ref24])^ No other organs were affected. Inflammation of bilateral auricles disappeared without any treatment, while iritis and scleritis were controlled by topical glucocorticoid therapy. Around 2 months prior to admission, he showed amnesia with gradual progression. One month prior to admission, he developed difficulty with drawing architectural drafts and finding his way home, together with emotional liability and urinary incontinence. Past medical history revealed well-controlled diabetes mellitus by diet and dipeptidyl peptidase-4 inhibitor (HbA1c was 6.4 to 6.7%).

On admission, his body temperature was 36.7°C, blood pressure was 112/66 mmHg and heart rate was 68 beats per minute. Physical examination revealed flared ears. Head, eye, ear, nose, chest and abdominal examinations were unremarkable. Neurological examination revealed poor tandem gait and poor finger-nose-finger test, but other examinations such as the cranial nerve, sensory and motor systems were unremarkable. He was euphoric and disoriented. His Mini-Mental States Examination (MMSE) result was 16 out of 30. Complete blood cell count, serum chemistry screening and endocrine function were unremarkable. Antinuclear antibodies, anti-neutrophil cytoplasmic antibodies, rheumatoid factor, anti-thyroid peroxydase antibody, anti-thyroglobulin antibody, urinalysis and serological tests for human immunodeficiency virus (HIV) and treponema pallidum were all normal or negative. Cerebrospinal fluid (CSF) analysis showed 33 cells/µl with 32 polymorphonuclear leukocytes, glucose 81 mg/dl and protein 92 mg/dl. CSF smear for Gram stain and acid-fast organisms stain were negative. CSF cultures for bacteria and *Mycobacterium tuberculosis* and polymerase chain reaction of *Herpes simplex virus* and cytology were also negative. Both anti-N-methyl-D-aspartate type glutamate receptor (GluR) N2B antibody and anti-GluR δ2 antibody were positive in CSF, but neither were positive in serum.

Whole body fluorine-18 fludeoxyglucose positron emission tomography (\[18F\]FDG-PET) with CT to detect tumor revealed no abnormal uptake. Comparing current brain magnetic resonance imaging (MRI) result with the previous ones indicated limbic system atrophy resulting in ventricular enlargement ([Fig. 2-A, B](#fig2){ref-type="fig"}). Diffusion weighted image, fluid-attenuated inversion recovery image (FLAIR) and gadolinium enhancement showed no abnormality. Electroencephalogram showed diffuse dominant theta waves with no spike.

Considering his clinical symptoms like emotional lability and amnesia, limbic system atrophy in MRI and increased number of CSF cells limbic encephalitis was diagnosed. Because other causes such as HIV encephalitis, herpes simplex encephalitis, tumor-associated limbic encephalitis or Hashimoto encephalopathy were ruled out, limbic encephalitis associated with RP was diagnosed, clinically. A course of intravenous 1 g methylprednisolone for 3 days was administered, followed by oral prednisolone 1 mg/kg per day. His cognitive function improved temporarily, but worsened again ([Fig. 3](#fig3){ref-type="fig"}). Subsequently infliximab 3 mg/kg was added to the prednisolone. His head MRI had no change but MMSE score was improved gradually, ataxia disappeared through 4 doses of infliximab over a 3-month period, and problematic behavior disappeared. Because of his stable condition as well as the high cost of infliximab, he and his wife refused further infliximab therapy. His condition continued to be stable without infliximab. Prednisolone was tapered down over a 16-month period and finally stopped. The patient was followed up for an additional 9 months after stopping prednisolone without recurrence ([Fig. 3](#fig3){ref-type="fig"}). At the end, he could continue active daily living independently, but could not resume his work.

DISCUSSION
==========

RP, a rare episodic and progressive inflammatory disease presumed to have autoimmune etiology, was first described in 1923.^[@ref25])^ RP affects cartilage in multiple organs, such as the ear, nose, larynx, trachea, bronchi, and joints.^[@ref25])^ In addition, it can affect proteoglycan-rich tissues such as the eyes, aorta, heart and skin.^[@ref25])^ The diagnosis of RP is usually made on the basis of clinical findings.^[@ref25])^ McAdam criteria^[@ref23])^ modified by Damiani and Levine,^[@ref24])^ which is commonly used as a criterion to confirm the diagnosis of RP, consists of: a) at least 3 of 6 clinical criteria (bilateral auricular chondritis, nonerosive seronegative inflammatory polyarthritis, nasal chondritis, ocular inflammation, respiratory chondritis and audiovestibular damage); b) 1 or more of the previously-mentioned clinical criteria and biopsy confirmation of cartilage inflammation; or c) chondritis at 2 or more separate anatomic locations with response to steroids and/or dapsone. This case fits criterion b).

RP with CNS manifestations is rare.^[@ref8],[@ref22])^ We searched MEDLINE in March 2014 using (\"Polychondritis, Relapsing\" \[Mesh\] OR \"Relapsing polychondritis\") AND (\"Encephalitis\" \[Mesh\] OR \"Limbic Encephalitis\" \[Mesh\] or encephalitis or encephalopathy or \"Limbic Encephalitis\" OR \"Meningoencephalitis\" \[Mesh\] OR Meningoencephalitis or \"nervous system\") as keywords. We retrieved a total of 54 articles, 26 of them including 31 cases that met inclusion criteria (case report or case series written in English or Japanese) ([Table 1](#table1){ref-type="table"}).^[@ref1]-[@ref22],[@ref26]-[@ref28])^

As shown in [Table 1](#table1){ref-type="table"}, 28 out of 31 patients have been treated with a high dose of glucocorticoid.^[@ref1]-[@ref22])^ Twenty-two out of those 28 patients had symptoms which were well-controlled by initial therapy, but only one could discontinue glucocorticoid therapy.^[@ref19])^ Six patients were refractory to initial glucocorticoid therapy.^[@ref3],[@ref4],[@ref7],[@ref9],[@ref11],[@ref12])^ Additional therapy (cyclophosphamide, intravenous immune globulin, tacrolimus, plasmapheresis, methotrexate and cyclosporin) showed no remarkable effect and 3 patients died.^[@ref3],[@ref4],[@ref7],[@ref11],[@ref12]^ Only one who was treated with inflixmab^[@ref9])^ had a good outcome, so we chose infliximab as a second-line agent.

This is the first case report of RP with CNS manifestations treated with an anti-TNF-α agent who did not show deterioration of signs and symptoms after stopping therapy.

Infliximab may be a good choice for RP with CNS manifestation refractory to initial glucocorticoid therapy.^[@ref9])^ Infliximab has a large molecular weight, so it is impossible for it to permeate the blood-brain barrier. Then why does it work? One potential explanation is that breakdown of the blood-brain barrier by inflammation may permit infliximab to access cerebral parenchyma, resulting in the suppression of TNF-α mediated inflammatory processes.^[@ref29])^ Although theoretically it may be reasonable to stop infliximab when neurologic symptoms are stable, if breakdown of the blood-brain barrier by inflammation is important for the effect of infliximab, it would be wise to closely observe the clinical course when discontinuing infliximab.

CONCLUSION
==========

Anti-TNF-α agents may be a treatment of choice for RP with CNS manifestations refractory to initial glucocorticoid therapy. In addition, anti-TNF-α agents may be discontinued, but it would be prudent to closely observe the clinical course when stopping infliximab.

![Histopathological examination of ear biopsy (hematoxylin-eosin stain) showed infiltration of inflammatory cells (histiocytes, lymphocytes, neutrophils and eosinophils) in perichondrium and chondrium.](2186-3326-76-361-g001){#fig1}

![(A) T2WI one year before admission; (B) T2WI of Day 1 showed ventricular enlargement compared to one year before admission; (C) there was no change after 6 months.](2186-3326-76-361-g002){#fig2}

![Clinical course. Cognitive function improved temporarily after methylpredonisolone pulse, but worsened again. MMSE score was improved gradually after infliximab.](2186-3326-76-361-g003){#fig3}

###### 

Abbreviations: T2WI, T2 weighted image. mPSL, methylpredonisolone. PSL, predonisolone. AZP, azathioprine. MONO, monocytes. PMN, polymorphonuclear leukocytes. CYC, cyclophosphamide. MTX, methotrexate. IVIG, intravenous immunoglobulin. nr, not reported.

Cases filled in red were refractory to initial glucocorticoid therapy. Cases filled in blue had good response to initial glucocorticoid therapy. Other patients received no treatment or the results were unknown.^[@ref5],[@ref7],[@ref21],[@ref27],[@ref28],[@ref30])^

\*The clinical course after the second pulse is not shown.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Year                      Age   Sex   Associated neurologic disorders (most patients had fever, headache or meningeal irritation signs)                                                                                                                     CSF Leucocytes (/mm 3)   MRI                                             Treatment                                            neurological response to initial therapy   neurological response at end of follow up   Outcome                                        treatment successfully dis­continued
  ----------- ------------- ----- ----- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------ ----------------------------------------------- ---------------------------------------------------- ------------------------------------------ ------------------------------------------- ---------------------------------------------- --------------------------------------
  this case                 58    M     amnesia, cognitive\                                                                                                                                                                                                   33\                      ventricular enlargement                         mPSL 1 g/day 3 days→\                                transitory                                 good                                        alive                                          **[yes]{.ul}**
                                        impairment, emotional\                                                                                                                                                                                                (32 PMN and\                                                             PSL 1 mg/kg/day→\                                                                                                                                                                          
                                        liability, urinary\                                                                                                                                                                                                   1 MONO)                                                                  +**[infliximab]{.ul}**→PSL\                                                                                                                                                                
                                        incontinence, euphoria                                                                                                                                                                                                                                                                         →stopped                                                                                                                                                                                   

  2011        ^[@ref9])^    57    M     generalized seizure, confusion                                                                                                                                                                                        700\                     T2WI high,\                                     high dose i.v. mPSL→\                                transitory                                 good                                        alive                                          no
                                                                                                                                                                                                                                                              (MONO 686)               gadolinium-enhanced                             high dose i.v. mPSL+CYC\                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                       →PSL+CYC→\                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                       PSL+MTX→**[infliximab]{.ul}**                                                                                                                                                              

  2011        ^[@ref7])^    52    M     amnesia, gait disorders and urinary incontinence, acalculia                                                                                                                                                           231\                     ventricular enlargement                         mPSL 500 mg+IVIG\                                    transitory                                 good or transitory\*                        alive                                          no
                                                                                                                                                                                                                                                              (PMN 161, MONO 69)                                                       30 g/day 5 days→\                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                       PSL 20 mg/day→\                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                       Steroid Pulse                                                                                                                                                                              

  2009        ^[@ref3])^    62    M     delirium, hallucinations, agitation, disinhibition, cognitive impairment, seizure, disturbed consciousness, recurrent clonic convulsion                                                                               39 (MONO 23)             FLAIR high                                      iv mPSL 3 days a week\                               transitory                                 worsend                                     alive                                          no
                                                                                                                                                                                                                                                                                                                                       3 weeks→iv mPSL 3 days\                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                       a week 4 weeks→\                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                       PSL 20 mg/day+tacrolimus 3 mg/day                                                                                                                                                          

  2008        ^[@ref12])^   51    M     coordination disorder, distractibility, emotional lability, insomnia, nocturnal myoclonic jerks, perseveration, attention and concentration deficits, confusion, speech latency, word-finding difficulty, myoclonus   39 (MONO 59)             high signal　abnormalities                      PSL 80 mg/day→\                                      worsened                                   worsend                                     died (after 10 months of neurological onset)   no
                                                                                                                                                                                                                                                                                                                                       Cyclophosphamide\                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                       150 mg/day                                                                                                                                                                                 

  2011        ^[@ref4])^    73    M     transitory loss of consciousness, confusion, disorientation, confabulation, aphasia, hallucinations, cognitive impairment                                                                                             89 (MONO 89)             FLAIR high, T2 high                             mPSL1500 mg 3 days→\                                 transitory                                 worsend                                     died (after 5 month of disease onset)          no
                                                                                                                                                                                                                                                                                                                                       3500 mg→\                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                       mPSL po 24 mg/day→\                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                       mPSL 1500 mg+ plasmapheresis→+IVIG                                                                                                                                                         

  2009        ^[@ref11])^   67    F     bradykinesia, disturbed consciousness, reduced willingness, walking disorder                                                                                                                                          73 (MONO 73)             FLAIR high                                      mPSL 1000 mg/day\                                    transitory                                 worsend                                     died (after 6 months of neurological onset)    no
                                                                                                                                                                                                                                                                                                                                       3 days→PSL 40 mg/day→\                                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                       PSL 60--50 mg/day\                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                       +MTX 6--8 mg/w+CyA\                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                       100--200 mg/day                                                                                                                                                                            

  1992        ^[@ref19])^   73    F     decreased consciousness, slow in mention, right eyelid paresis, slight unilateral facial weakness                                                                                                                     nr                       nr                                              PSL 100 mg/day→\                                     good                                       good                                        alive                                          **[yes]{.ul}**
                                                                                                                                                                                                                                                                                                                                       +Cyc 100 mg/day→\                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                       PSL 5 mg/day→both stopped                                                                                                                                                                  

  2011        ^[@ref7])^    44    M     amnesia, irritated, anxious                                                                                                                                                                                           190 (PMN17 MONO 171)     T2WI high                                       mPSL 200 mg 5 days→\                                 good                                       good                                        alive                                          no
                                                                                                                                                                                                                                                                                                                                       120 mg/day one week→\                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                       PSL 60 mg/day\                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                       +AZP 100 mg/day→PSL 25 mg/day+AZP 100 mg/day                                                                                                                                               

  2011        ^[@ref7])^    44    F     anxiety, insomnia                                                                                                                                                                                                     70 (PMN 28 MONO 42)      normal                                          mPSL 500 mg iv→mPSL 120 mg/day→+AZP                  good                                       good                                        alive                                          no

  2011        ^[@ref8])^    68    F     dysarthria, disorientation, impaired language function, agraphia                                                                                                                                                      100 (PMN 33, MONO 67)    high intensity                                  mPSL 1 g 3 days→\                                    good                                       good                                        alive                                          no
                                                                                                                                                                                                                                                                                                                                       PSL 1 mg/kg/day→10 mg/day                                                                                                                                                                  

  2010        ^[@ref10])^   70    M     confusion, hallucinations                                                                                                                                                                                             38                       T2WI high, gadolinium enhancement               mPSL 1 g 3 days→\                                    good                                       good                                        alive                                          no
                                                                                                                                                                                                                                                                                                                                       PSL 1 mg/kg/day→15 mg/day                                                                                                                                                                  

  2008        ^[@ref13])^   66    F     bradykinesia, somnolence, urinary incontinence, mutism, disorientation                                                                                                                                                90                       T1WI low, T2WI high, FLAIR high                 mPSL 1000 mg/day 3 days                              good                                       good                                        alive                                          no

  2008        ^[@ref12])^   68    M     comprehension problems, emotional lability, confusion, language problems, amnesia, executive dysfunction, visuospatial impairment, mild anomia                                                                        4 (MONO 2)               T2WI high                                       PSL 80 mg/day                                        good                                       good                                        alive                                          no

  2007        ^[@ref14])^   40    M     confusion, somnolence                                                                                                                                                                                                 1500 (PMN 1245)          T2WI high, FLAIR high                           intravenous steroid therapy                          good                                       good                                        alive                                          no

  2007        ^[@ref26])^   64    M     amnesia, disorientation, acalculia, reduced willingness                                                                                                                                                               14 (MONO 14)             T2WI high, FLAIR high                           PSL 30 mg po→\                                       good                                       good                                        alive                                          no
                                                                                                                                                                                                                                                                                                                                       PSL 20 mg/day po                                                                                                                                                                           

  2006        ^[@ref15])^   71    F     confuse, aphasia, weakness of right extremities                                                                                                                                                                       110 (MONO 100)           enhanced                                        hydrocortisone 200 mg/day→\                          good                                       good                                        alive                                          no
                                                                                                                                                                                                                                                                                                                                       PSL 60 mg/day→\                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                       PSL 20 mg/day                                                                                                                                                                              

  2004        ^[@ref17])^   38    M     right-side weakness, diplopia, right side hemipregia, with hyperreflexia and clonus at the ankle, confuse                                                                                                             nr                       T2WI high                                       corticosteroid therapy→\                             good                                       good                                        alive                                          no
                                                                                                                                                                                                                                                                                                                                       PSL 1 mg/kg/day+AZP                                                                                                                                                                        

  2004        ^[@ref2])^    45    M     confusion, euphoria, hyperactive behavior, disorientation, amnesia, fever, inappropriately jocular affect, disjointed speech, confabulation, attention deficits                                                       8000 (MONO 7520)         T2WI high                                       high dose mPSL→\                                     good                                       good                                        alive                                          no
                                                                                                                                                                                                                                                                                                                                       PSL 40 mg/day                                                                                                                                                                              

  2004        ^[@ref16])^   49    M     disorientation, somnolent, ataxic, disorientation, gait disorder                                                                                                                                                      145 (PMN 55 MONO 81)     T2WI high                                       1 g mPSL 3 days→\                                    good                                       good                                        alive                                          no
                                                                                                                                                                                                                                                                                                                                       PSL 40 mg/day a week→\                                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                       20 mg→10 mg/day+ 200 mg hydroxychloroquine per day                                                                                                                                         

  2004        ^[@ref1])^    57    M     amnesia, anxiety, depressive state                                                                                                                                                                                    119 (MONO 105)           T2WI high, FLAIR high, gadolinium enhanced      mPSL 1 g/day 3 days 2 course\                        good                                       good                                        alive                                          no
                                                                                                                                                                                                                                                                                                                                       →60 mg/day                                                                                                                                                                                 

  2004        ^[@ref2])^    62    M     acalculia, confusion, euphoria, amnesia                                                                                                                                                                               24000 (MONO 21360)       T2WI high, FLAIR high                           methylprednisone pulse→\                             good                                       good                                        alive                                          no
                                                                                                                                                                                                                                                                                                                                       PSL 40 mg/day po                                                                                                                                                                           

  1995        ^[@ref18])^   36    M     horizontal diplopia                                                                                                                                                                                                   5 (5 MONO)               T2WI high, gadolinium enhancement               PSL 20 mg taper over 2 weeks→\                       good                                       good                                        alive                                          no
                                                                                                                                                                                                                                                                                                                                       30 mg/day→3 months→\                                                                                                                                                                       
                                                                                                                                                                                                                                                                                                                                       10 mg/day                                                                                                                                                                                  

  1991        ^[@ref20])^   64    M     change in mental status, hallucination                                                                                                                                                                                100 (2PMN, 96 MONO)      nr                                              PSL 100 mg iv→\                                      good                                       good                                        alive                                          no
                                                                                                                                                                                                                                                                                                                                       60 mg/day→\                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                       +Cyclophosphamide\                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                       125 mg/day                                                                                                                                                                                 

  1983        ^[@ref22])^   58    F     unsteady in walking, confused, hallucination, disorientation, nystagmus, facial weakness                                                                                                                              nr                       nr                                              PSL 80 mg/day→\                                      good                                       good                                        alive                                          no
                                                                                                                                                                                                                                                                                                                                       dapson 200 mg/day                                                                                                                                                                          

  2012        ^[@ref6])^    60    M     acalculia, dyslexia,\                                                                                                                                                                                                 138 (MONO 128 PMN 10)    FLAIR high, enhanced                            PSL iv→PSL po 20 mg                                  good                                       good                                        improved                                       no
                                        right left agnosia,\                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                        mild right hemiplesia                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  1984        ^[@ref21])^   51    M     left facial weakness, ataxia, dementia, confuse                                                                                                                                                                       normal                   nr                                              steroid                                              no                                         no                                          alive                                          no

  2011        ^[@ref7])^    54    M     bipolar disorder, fmemory loss, hallucinations, amnesia, disorientation, insomnia, irritability                                                                                                                       800 (MONO 800)           T2WI high                                       mPSL 1000 mg iv 3 days→\                             nr                                         good                                        alive                                          no
                                                                                                                                                                                                                                                                                                                                       PSL 80 mg/day+AZP                                                                                                                                                                          

  2009        ^[@ref5])^    29    M     nr                                                                                                                                                                                                                    32 (PMN 32)              T2WI high, FLAIR high                           oral steroid→\                                       nr                                         nr                                          alive                                          no
                                                                                                                                                                                                                                                                                                                                       azathioprine+adalimumab                                                                                                                                                                    

  2000        ^[@ref28])^   75    F     tremor                                                                                                                                                                                                                nr                       T2WI high                                       nr                                                   nr                                         nr                                          alive                                          no

  2008        ^[@ref30])^   61    M     convulsions, dicreased interest, slurred speech, hallucinations, somnolent, rigidity                                                                                                                                  312 (MONO 299)           T2WI high, FLAIR high, gadolinuim enhancement   no treatment (supportive therapy alone)              good                                       good                                        alive                                          no

  2006        ^[@ref27])^   53    M     cognitive impairment, difficulties with problem solving, amnesia, uncharacteristically aggressive and abusive behavior, disorientation, psychomotor dysfunction                                                       nr                       DWI high                                        palliative care                                      no (no treatment)                          no (no treatment)                           died (after 18 months from onset)              no
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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